<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR10">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Dyall</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Coleman</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Hart</surname>
    <given-names>BJ</given-names>
   </name>
   <name>
    <surname>Venkataraman</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Holbrook</surname>
    <given-names>MR</given-names>
   </name>
   <name>
    <surname>Kindrachuk</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Johnson</surname>
    <given-names>RF</given-names>
   </name>
   <name>
    <surname>Olinger</surname>
    <given-names>GG</given-names>
    <suffix>Jr</suffix>
   </name>
   <name>
    <surname>Jahrling</surname>
    <given-names>PB</given-names>
   </name>
   <name>
    <surname>Laidlaw</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Johansen</surname>
    <given-names>LM</given-names>
   </name>
   <name>
    <surname>Lear-Rooney</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Glass</surname>
    <given-names>PJ</given-names>
   </name>
   <name>
    <surname>Hensley</surname>
    <given-names>LE</given-names>
   </name>
   <name>
    <surname>Frieman</surname>
    <given-names>MB</given-names>
   </name>
  </person-group>
  <article-title>Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection</article-title>
  <source>Antimicrob Agents Chemother</source>
  <year>2014</year>
  <volume>58</volume>
  <issue>8</issue>
  <fpage>4885</fpage>
  <lpage>4893</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.03036-14</pub-id>
  <pub-id pub-id-type="pmid">24841273</pub-id>
 </element-citation>
</ref>
